![](/media/vdqhqzem/salmon.png)
Uppsala Reports editor
@UMCGlobalSafety
The liver, responsible for drug metabolism in the body, is also most at risk of damage due to medicines. Unravel the complexities of DILI and its impact on medication safety.
When it comes to our health, the liver plays a crucial role in processing and detoxifying substances, including medications. However, it can also be badly damaged by medicines and their compounds, resulting in drug-induced liver injury (DILI). In the latest episode of Drug Safety Matters, Rita Baião from the North Lisbon University Hospital Center discusses the complexities of DILI, who is most at risk of developing it, and the proactive measures taken during drug development to mitigate damage.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
With the misinformation pandemic still rife on the internet, finding websites with scientifically accurate vaccine information is quite the task. The VSN aims to change that.
Communications / 17 June 2024
We take a deep dive into the world of serious and unexpected adverse events, termed 'black swan' events, and their profound impact on drug safety, healthcare, and patient care.
Communications / 04 March 2024
The latest WHO PIDM film celebrates the long-standing collaboration between WHO and UMC to fulfil the mission of making medicines and vaccines safer for everyone.
Communications / 11 March 2024